ARCT
Arcturus Therapeutics Holdings Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +30.0% ·
flujo de acciones +13.3% ·
nuevas posiciones netas +20.0%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | +4 | 19.18M | $128.95M | +5 | −1 |
| Q1 2026 | 60 | 0 | 18.54M | $142.94M | +4 | −4 |
| Q4 2025 | 60 | 0 | 18.71M | $114.66M | +3 | −3 |
| Q3 2025 | 16 | -1 | 10.27M | $189.25M | +1 | −2 |
| Q2 2025 | 14 | +1 | 8.29M | $107.85M | +2 | −1 |
| Q1 2025 | 10 | +3 | 4.50M | $47.65M | +3 | — |
| Q4 2024 | 7 | -2 | 3.97M | $67.41M | — | −2 |
| Q3 2024 | 8 | -2 | 3.11M | $72.14M | — | −2 |
| Q2 2024 | 10 | — | 3.78M | $92.06M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 2.01M | +3.9% | $21.27M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.28M | -3.5% | $13.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 569.62K | +2.6% | $6.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 569.62K | +2.6% | $6.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 461.91K | Nuevo | $4.89M | 0.0% | New | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 92.87K | -4.3% | $983,535 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 92.87K | -4.3% | $983,535 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 37.35K | +35.5% | $395,589 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 20.12K | +5.8% | $214,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 12.07K | Nuevo | $127,790 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 12.07K | Nuevo | $127,790 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 12.07K | Nuevo | $127,790 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 12.07K | Nuevo | $127,790 | 0.0% | New | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 10.32K | Nuevo | $109,257 | 0.0% | New | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 6.34K | -53.6% | $67,172 | 0.0% | ▼ Trim | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $4.89M | 0.0% |
| AQR Capital Management | $127,790 | 0.0% |
| AQR Capital Management | $127,790 | 0.0% |
| AQR Capital Management | $127,790 | 0.0% |
| AQR Capital Management | $127,790 | 0.0% |
| Point72 Asset Management | $109,257 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 124 tenedores, 24.09M acciones, $182.18M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.